カイジェンは、大正製薬とこの独占的ライセンス契約を締結しました。これは、同社の次世代自己免疫疾患治療薬「KG006」の開発および、特に日本における商業化を支援することを目的としています。つまり、基本的にはこの契約に基づき……
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced…
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing…
Veeva Systems announced that Boehringer Ingelheim has launched its own drug discovery…
Astellas Pharma and YASKAWA Electric have agreed to form a joint venture.…
Agatica Inc., which promotes cashless medical care, is pleased to announce that…
JiMED Inc., a developer of wireless implantable BMI system medical devices, has…
Boston Medical Sciences Co., Ltd. is pleased to announce that it has…
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work…
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced…
Parse Biosciences, the leading provider of accessible and scalable single cell sequencing…
Veeva Systems announced that Boehringer Ingelheim has launched its own drug discovery…
Astellas Pharma and YASKAWA Electric have agreed to form a joint venture.…
Agatica Inc., which promotes cashless medical care, is pleased to announce that…
JiMED Inc., a developer of wireless implantable BMI system medical devices, has…
Boston Medical Sciences Co., Ltd. is pleased to announce that it has…
PHC Corporation has signed a Master Collaboration Agreement with CCRM to work…
アカウントにサインインする